Granules India Ltd. News and Updates

Name: Latest research reports of Granules India Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Granules India Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news on Granules India Ltd. from all sources in a single place.

Granules India Ltd.

10 Apr 2025

464.40

2.90%

Granules India completes acquisition of Swiss CDMO Senn Chemicals AG

Business Standard

The acquisition was executed through Granules' wholly owned subsidiary, Granules Peptides

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India completes acquisition of Senn Chemicals

Business Line | 10 Apr 2025

Granules India Ltd.

25 Mar 2025

464.40

2.90%

Granules India's Board Approves Restructuring Plan Involving US Subsidiaries

NDTV Profit

Granules India's plan is expected to reduce the number of legal entities, simplify the legal, tax, and operational structures, create a unified holding structure, and improve the market focus.

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India Ltd.

09 Mar 2025

464.40

2.90%

USFDA flags Granules India for storage, equipment lapses at Telangana plant

Business Standard

The US health regulator has pulled up Granules India for failing to maintain buildings for drug storage and avoiding adequate procedures regarding cleaning and maintenance of equipment at its Telangana-based formulations plant. In a warning letter to the company's Chairman and Managing Director Krishna Prasad Chigurupati, the US Food and Drug Administration (USFDA) stated that the company failed to establish and follow adequate written procedures for maintaining equipment at the Medchal-Malkajgiri-based manufacturing facility. The USFDA inspected the facility from August 26 to September 6, 2024. "Our investigators observed significant contamination in multiple ducts of non-dedicated use in the preparation of finished drug products manufactured at your facility," the USFDA stated. While filters were installed to prevent contamination, inadequate cleaning and maintenance processes rendered them ineffective, it added. "Swab samples collected from the ducts by your firm during the...

Granules India Ltd. is trading below all available SMAs

USFDA rebukes Granules India for lapses in maintaining storage facilities, equipment at Telangana plant

Business Line | 09 Mar 2025

Granules India Ltd.

05 Mar 2025

464.40

2.90%

Granules India Fails To Follow US FDA Mandated Safety Procedures

NDTV Profit

The US FDA said there were violation of current good manufacturing practice regulations for finished pharmaceuticals, at Granules India's Gagillapur facility.

Granules India Ltd. has lost -20.45% in the last 3 Months

Granules India Ltd.

04 Mar 2025

464.40

2.90%

LIC raises stake in Granules India to 5.02%. Do you own?

livemint

Granules India share price has declined by 16.55% over the past month and over 20% on a year-to-date (YTD) basis. In the last six months, the pharma stock has dropped more than 32%.

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

28 Feb 2025

464.40

2.90%

Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility

livemint

Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing four concerns. The company confirmed progress in addressing these issues while maintaining product distribution.

Granules India Ltd. is trading below all available SMAs

Granules India Share Price Hits Over Eight-Month Low After US FDA Issues Warning

NDTV Profit | 28 Feb 2025

Granules India Ltd.

21 Feb 2025

464.40

2.90%

Granules India Acquires Swiss CDMO Firm Senn Chemicals AG For CHF 20 Million

NDTV Profit

The acquisition is expected to be completed in the first half of 2025, Granules India said in a statement.

Granules India Ltd. is trading below all available SMAs

Granules acquires Swiss firm for Rs 192 crore; forays into CDMO space

Business Standard | 21 Feb 2025

Granules India Ltd.

21 Feb 2025

464.40

2.90%

Granules India to acquireSenn Chemicals AG for 192 crore

Business Line

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India Ltd.

17 Feb 2025

464.40

2.90%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

30 Jan 2025

464.40

2.90%

Granules India gets USFDA's nod forADHD generic

Business Line

With this latest approval, Granules India Ltd Limited now holds a total of 69 ANDA approvals, with 38 secured under the name of Granules India Limited (GIL) and 31 under Granules Pharmaceuticals, Inc. (GPI)